Infusion reactions to the chimeric EGFR inhibitor cetuximab—change to the fully human anti-EGFR monoclonal antibody panitumumabn         is safe

J. Thaler

首页> 外文期刊>Annals of Oncology >Infusion reactions to the chimeric EGFR inhibitor cetuximab—change to the fully human anti-EGFR monoclonal antibody panitumumabn is safe

【24h】

Infusion reactions to the chimeric EGFR inhibitor cetuximab—change to the fully human anti-EGFR monoclonal antibody panitumumabn is safe

机译：嵌合EGFR抑制剂西妥昔单抗的输注反应-更改为完全人源抗EGFR单克隆抗体panitumumabn是安全的

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of Oncology》 |2011年第2期|p.486-487|共2页
作者
J. Thaler;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe. [J] . Resch G, Schaberl Moser R, Kier P, Annals of oncology: official journal of the European Society for Medical Oncology . 2011,第2期

机译：嵌合EGFR抑制剂西妥昔单抗的输注反应-改为完全人类抗EGFR单克隆抗体panitumumab的输注反应是安全的。
2. Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab. [J] . Helbling D, Borner M Annals of oncology: official journal of the European Society for Medical Oncology . 2007,第5期

机译：与嵌合EGFR抗体西妥昔单抗的输注反应后，使用完整的人EGFR抗体panitumumab成功挑战。
3. Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab [J] . D Helbling and M Borner Annals of Oncology . 2007,第5期

机译：与嵌合EGFR抗体西妥昔单抗的输注反应后，使用完整的人EGFR抗体panitumumab成功挑战
4. Identification and Characterization of Deamidation in anti-EGFR Monoclonal Antibody Cetuximab [C] . Authors: Li Yang, Tun Liu, Jay Charlebois, ASMS Conference on Mass Spectrometry and Allied Topics . 2006

机译：抗EGFR单克隆抗体乙酸中脱酰胺的鉴定与表征
5. Characterization of Anti-Ricin Monoclonal Antibodies and the Construction of a Chimeric Murine-Human IgG2/K Anti-Ricin Monoclonal Antibody [D] . Vendramelli, Robert Matthew 2011

机译：抗蓖麻毒蛋白单克隆抗体的表征和鼠/人IgG2 / K嵌合抗蓖麻毒蛋白单克隆抗体的构建
6. Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells [O] . Rosita Russo, Nunzia Matrone, Valentina Belli, 2019

机译：巨噬细胞迁移抑制因子是人类大肠癌细胞抗EGFR单克隆抗体西妥昔单抗耐药的分子决定因素。
7. Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab [O] . Helbling, D., Borner, M. 2017

机译：与嵌合EGFR抗体西妥昔单抗的输注反应后，使用完整的人EGFR抗体panitumumab成功挑战

Infusion reactions to the chimeric EGFR inhibitor cetuximab—change to the fully human anti-EGFR monoclonal antibody panitumumabn is safe

著录项

相似文献

相关主题

期刊订阅